CML patients show mostly M-bcr BPs resulting in a b2a2 or b3a2 transcript, containing BCR exon 13 (b2) or 14 (b3) and ABL1 exon 2 (a2) [12]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.